|
CDC123 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.793800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.165900E-02 |
| Normal-vs-Stage2 |
5.171400E-01 |
| Normal-vs-Stage3 |
5.662200E-01 |
| Normal-vs-Stage4 |
8.851800E-01 |
| Stage1-vs-Stage2 |
4.263800E-01 |
| Stage1-vs-Stage3 |
1.796990E-01 |
| Stage1-vs-Stage4 |
4.757600E-02 |
| Stage2-vs-Stage3 |
8.548200E-01 |
| Stage2-vs-Stage4 |
4.835000E-01 |
| Stage3-vs-Stage4 |
5.326800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.083400E-01 |
| Normal-vs-AfricanAmerican |
1.219850E-01 |
| Normal-vs-Asian |
2.619800E-02 |
| Caucasian-vs-AfricanAmerican |
4.326200E-01 |
| Caucasian-vs-Asian |
1.703370E-01 |
| AfricanAmerican-vs-Asian |
8.122200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.346400E-01 |
| Normal-vs-Female |
7.740400E-02 |
| Male-vs-Female |
7.872200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.556200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.175200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.083600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.257150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.241000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.535170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.990400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.452400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.056400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.251200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.026200E-01 |
| Classical-VS-Follicular |
5.368800E-01 |
| Classical-VS-Other |
2.514800E-01 |
| Classical-VS-Normal |
2.044100E-02 |
| Tall-VS-Follicular |
8.184000E-01 |
| Tall-VS-Other |
5.604800E-01 |
| Tall-VS-Normal |
6.221400E-01 |
| Follicular-VS-Other |
5.568000E-01 |
| Follicular-VS-Normal |
3.766600E-01 |
| Other-VS-Normal |
7.574200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.387600E-01 |
| Normal-vs-N1 |
5.911600E-01 |
| N0-vs-N1 |
1.893400E-01 |
|
|
